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1. Introduction 
The copper enzyme dopamine ~-hydroxylase 
(dopamine/~-mono-oxygenase: EC 1.14.17.1), which 
catalyzes the hydroxylation of dopamine to noradren- 
aline has been located within the limiting membrane 
of the chromaff'm granules of adrenal medulla [1,2]. 
In this typical mono-oxygenase reaction ascorbate 
supports high rates of hydroxylation catalyzed by 
the solubilized or the purified enzyme [3], but 
whether or not this vitamin functions as the electron 
donor for the enzyme in rive, is still uncertain. Thus, 
while ascorbate isan effective donor when tested on 
highly purified enzyme, one cannot be certain if this 
is also the case during hydroxylation i  rive since no 
decrease in the tissue levels of catecholamines has 
been detected in the severely scorbutic guinea pig 
[4,5]. Furthermore, in his estimations of the ascor- 
bate content of the subcellular f actions of bovine 
adrenal medulla Hagen [6] found little if any as- 
corbate in the cytoplasmic particles. Although 
indirect evidence has been presented for the presence 
of reducing equivalents in the intact chromaffin 
granules [1,7], the function of ascorbate has not 
yet been demonstrated. 
In support of the function of ascorbate in the 
hydroxylation of dopamine in the adrenal medulla 
we report hat the chromaffin granules contain a 
high concentration f this vitamin in its fully reduced 
form. 
Abbreviations: DCPI, 2,6-dichlorophenolindophenol. 
2. Methods 
2.1. Preparation of protein-free lysate of chromaffin 
granules 
Chromaffin granules were prepared from bovine 
adrenal medulla by sedimentation in 1.6 M sucrose 
as described [8]. The granules were then subjected 
to hypo-osmotic lysis and soluble proteins were pre- 
cipitated by 50% (v/v) ethanol in 10 mM acetic acid 
containing 1 mM EDTA [9]. The pH was adjusted to 
3.0 by 0.5 M HCI, and following an incubation period 
of 1 h at 0°C the precipitated proteins were removed 
by centrifugation. 
2.2. Chromatographic procedures 
Catecholamines of the protein-free lysate (pH 
adjusted to 5.3) were quantitatively removed by 
adsorption onto a column of the strong cation- 
exchange resin Dowex 50W-X8 (Na + form) [10] 
equilibrated with 10 mM Na-acetate buffer, pH 5.3 
containing 1 mM EDTA. 
Ascorbate [11] as well as adenine nucleotides of 
the protein-free lysate (pH adjusted to 5.3) were 
quantitatively removed by adsorption onto a column 
of the moderately strong an!on-exchangeresin 
Dowex 2 (acetate form) equilibrated with 10 mM 
Na-acetate buffer, pH 5.3 containing 1 mM EDTA. 
The low-molecular weight compounds of the 
protein-free lysate were separated on a column 
(1.9 cm X 46 cm) of Sephadex G-10 (Pharmacia 
Fine Chemicals, Sweden) equilibrated and eluted 
(10 ml/h) with 10 mM Na-acetate buffer, pH 5.3 
or pH 3.3, containing I mM EDTA and 0.3 M NaC1. 
was added to the buffer in order to increase the 
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Fig.l. Absorbance at245 nm (o) and 280 nm (zx) and 2,6-dichlorophenolindophenol (DCPI) reducing ability (o) of the 
fractions (1.6 ml) of the acid ethanol-soluble portion of the chromaffin granule lysate, after separation on Sephadex G-10. 
The column (1.9 × 46 cm) was equilibrated and eluted with 1~0 mM Na-acetate buffer, pH 3.3 containing 0.3 M NaC1 and 
1 mM EDTA. 
retardation of the catecholamines typical of aromatic 
compounds [12] and thus achieve a separation from 
e.g. ascorbate in spite of nearly identical molecular 
weights, as well as a separation of adrenaline from 
noradrenaline (see fig. 1). Aliquots were assayed for 
absorbance at245 nm and 280 nm and titrated with 
2,6-dichlorophenolindophenol to locate ascorbic 
acid/ascorbate containing fractions (see below). 
EDTA (1 mM) was included in all buffers used in 
order to protect he ascorbate from oxidation since 
metal ions catalyze the autoxidation of this vita- 
min [13]. 
2.3. Analytical methods 
Ascorbate was assayed by its reduction of 2,6- 
dichlorophenolindophenol (from the Sigma Chemical 
Co., U.S.A.) at pH 7.0 (0.1 M K-phosphate buffer) 
as followed spectrophotometrically (Shimadzu model 
MPS.50L recording spectrophotometer) by the 
decrease in absorbance at600 nm, using the extinc- 
tion,c~efficient 16.1 mM -1 cm -l [14]. 
~drenaline and noradrenaline were identified by 
a high-speed amino-acid analyzer (Bio-Cal, type 
BC-200) [9] and assayed spectrophotometrically 
using the extinction coefficient 2.6 mM -m cm -~ at 
280 nm for both components (O. Terland, unpu- 
blished results). 
L-Ascorbic acid was the product of Baker Chemi- 
cals, The Netherlands. Quartz distilled water was used 
throughout. 
3. Results 
3.1. Demonstration and assay of DCPI-reducing 
substance(s) of the chromaffin granule lysate 
The chromaff'm granule lysate, from which pro- 
teins had been removed by acid-ethanol precipitation, 
was assayed for substances,able to reduce 2,6-dichloro- 
phenolindophenol (DCPI) as well as for cate- 
cholamines (table 1). Quite unexpected was the 
finding that the catecholamine-free lysate contained 
high concentrations,of DCPI-reducing substance(s). 
Furthermore, it is seen from table 1 that there is an 
almost constant molar ratio between the cate- 
cholamines and the DCPI reduced when determined 
on different preparations of adrenal medulla (the 
molar ratio was approx. 40:1 as an average of 6 deter- 
minations). This result indicates that the naturally 
occurring reducing substance(s) i  present in the 
chromaffin granule matrix at a concentration of
about 13 mM assuming a two-electron donor and a 
concentration of 0.55 M for the catecholamines [15]. 
3.2. Identification of the ma/or DCPI-reducing sub- 
stance 
Molecular-sieve chromatography onSephadex 
G-10 of the acid ethanol-soluble portion of the 
granule lysate gave four distinct UV-absorbing peaks 
in the elution diagram (fig.l). The first peak (at 28 
ml) was identified spectroscopically as adenine 
nucleotides whereas the third peak (at 86 ml) and 
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Table 1 
The molar atio of catecholamines to DCPI reducing 
in the lysate of chromaffin granules 
substance(s) 
Expt. No. Catecholamines DCPI reduced 
(#mol) (#mol) 
Molar ratio 
catecholamines 
DCPI reduced 
1 a 9.2 0.227 40.5 
2 a 8.2 0.213 38.5 
3 a 8.9 0.212 42.0 
4 a 8.7 0.215 40.5 
5 b 25.0 0.653 38.3 
6 b 25.7 0.627 41.0 
aDerived from 1.66 g of medulla (wet wt) 
bDerived from 1.4 g of medulla (wet wt) 
The amount of DCPI reduced was determined after the catecholamines had been 
removed as described in Methods. The amount of catecholamines (adrenaline 
plus noradrenaline) was determined after DCPl-reducing substance(s) and 
adenine nucleotides had been removed as described in Methods. The data in Expt. 
No. 5 and 6 were obtained from experiments identical to that given in rigA. 
November 1975 
fourth peak (at 114 ml) were found to represent 
adrenaline and noradrenaline, respectively. The 
second peak (at 54 ml), which was found to contain 
material which rapidly reduced DCPI, was well sepa- 
rated from adenine nucleotides and catecholamines 
at pH 3.3, and co-chromatographed with L-ascorbic 
acid/ascorbate at this pH as well as at pH 5.3 (table 2). 
The identity of this DCPI-reducing substance with 
ascorbic acid/ascorbate was confirmed by a compa- 
rison of the u.v. absorption spectrum of the peak 
Table 2 
The elution volumes of ascorbic acid/ascorbate, he DCPI- 
reducing substance, adenine nucleotides, adrenaline and 
noradrenaline at two different pH values on molecular 
sieve chromatography (Sephadex G-10) 
Compound Elution volume (ml) 
pH 3.3 pH 5.3 
Ascorbic acid/ascorbate 55 42 
DCPI-reducing substance 54 43 
Adenine nucleotides a 28 28 
Adrenaline 86 86 
Noradrenaline 114 114 
aMainly ATP 
Experimental conditions as in fig.1. The volumes are the 
mean of two determinations. 
fractions (equivalent to 56/aM DCPI) with an 
authentic sample of L-ascorbic acid/ascorbate at 
strongly acidic pH (fig.2A) and pH 5.3 (fig.2B). 
Since the molar ratio between the catecholamines 
and the ascorbate thus determined was also approx. 
40:1 (table 1) it may be concluded that the major 
DCPI reducing component of  the chromaffin 
granules is ascorbate. 
Although we do not know why ascorbic acid/ 
ascorbate revealed a strongly pH-dependent elution 
profile on the Sephadex G-10 column (table 2), our 
data may indicate that the vitamin exists as a dimer 
in its dissociated form. 
4. Discussion 
Previous observations [1,7] that preparations of
crude chromaff'm granules of adrenal medula con- 
vert dopamine into noradrenaline even in the absence 
of added ascorbate, indicated the presence of 
reducing equivalents in the granules although the 
conclusion of a more direct study was negative [6]. 
From the data presented here, however, it is apparent 
that the chromaffin granule matrix contains appreci- 
able amounts of a DCPI-reducing substance. This 
substance was identified as ascorbic acid/ascorbate 
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Fig.2. The solid lines represent the u.v. absorption spectra of the DCPI-reducing substance luted from the Sephadex G-10 
column at 54 ml (see fig.l) recorded at pH 1.0 (A) and pH 5.3 (B). The amount of material was equivalent to 56 ~amol f DCPI. 
The broken lines represent the spectra of 55 t~mol of an L-ascorbic acid/ascorbate standard solution. The common baselines are 
indicated in each figure. 
by its chromatographic behavior on Sephadex G-10 
and its spectral comparison with an authentic sample 
of L-ascorbic acid/ascorbate. 
On the basis of our discovery and estimates on 
the average ascorbate content of the chromaffin 
granule matrix (approx. 13 mM), which is well above 
the K M value of dopamine/~-hydroxylase in an in 
vitro assay system [16,17], as well as the localization 
of this enzyme within the limiting membrane of the 
granules [1,2], it is likely that ascorbate indeed 
functions as the immediate lectron donor also in 
vivo. 
Since dehydroascorbate is formed when the oxida- 
tion of ascorbate is coupled to the l~-hydroxylation 
of dopamine [3] and it has been reported that a 
conjugated form of ascorbate (ascorbate 2-sulfate) 
is present in the adrenal gland [18] a more detailed 
analysis of the content of these compounds in the 
chromaffin granules is now in progress. 
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